DPP-4 inhibitors: Revision history

22 September 2019

• curprev 18:4318:43, 22 September 2019‎ ClaireLewis talk contribs‎ 2,382 bytes −396‎ No edit summary

18 January 2017

• curprev 13:2113:21, 18 January 2017‎ Rossdonaldson1 talk contribs‎ 2,778 bytes +40‎ →‎References

31 December 2016

• curprev 02:4502:45, 31 December 2016‎ Mholtz talk contribs‎ 2,738 bytes −527‎ Updated formatting - page will need further modification

30 December 2016

• curprev 19:1519:15, 30 December 2016‎ H KDHCD H talk contribs‎ 3,265 bytes +141‎ →‎References
• curprev 19:1219:12, 30 December 2016‎ H KDHCD H talk contribs‎ 3,124 bytes +40‎ →‎Mechanism of Action
• curprev 19:1119:11, 30 December 2016‎ H KDHCD H talk contribs‎ 3,084 bytes +4‎ →‎Mechanism of Action
• curprev 19:0919:09, 30 December 2016‎ H KDHCD H talk contribs‎ 3,080 bytes +128‎ →‎References
• curprev 19:0919:09, 30 December 2016‎ H KDHCD H talk contribs‎ 2,952 bytes +143‎ →‎Indications
• curprev 19:0219:02, 30 December 2016‎ H KDHCD H talk contribs‎ 2,809 bytes +1,144‎ →‎Adverse Effects
• curprev 18:5718:57, 30 December 2016‎ H KDHCD H talk contribs‎ 1,665 bytes −16‎ →‎Mechanism of Action
• curprev 18:5518:55, 30 December 2016‎ H KDHCD H talk contribs‎ 1,681 bytes +445‎ →‎Mechanism of Action
• curprev 07:1507:15, 30 December 2016‎ H KDHCD H talk contribs‎ 1,236 bytes +805‎ No edit summary

• curprev 06:5606:56, 30 December 2016‎ H KDHCD H talk contribs‎ 431 bytes +431‎ Created page with "=== '''Introduction''' === Dipeptidyl Peptidase-4 Inhibitors (gliptans) are oral hypoglycemics that block DPP-4. This leads to an increase in the activity of incretins, which..."